Skip to main content
Top
Literature
1.
go back to reference Jodkowska A, Martynowicz H, Kaczmarek-Wdowiak B, Mazur G (2015) Thrombocytopenia in pregnancy—pathogenesis and diagnostic approach. Postepy Hig Med Dosw (Online) 69:1215–1221CrossRef Jodkowska A, Martynowicz H, Kaczmarek-Wdowiak B, Mazur G (2015) Thrombocytopenia in pregnancy—pathogenesis and diagnostic approach. Postepy Hig Med Dosw (Online) 69:1215–1221CrossRef
4.
5.
go back to reference Boehlen F (2006) Thrombocytopenia during pregnancy. Importance, diagnosis and management. Hamostaseologie 26(1):72–74 (quiz 75–78) CrossRefPubMed Boehlen F (2006) Thrombocytopenia during pregnancy. Importance, diagnosis and management. Hamostaseologie 26(1):72–74 (quiz 75–78) CrossRefPubMed
7.
go back to reference Sainio S, Kekomaki R, Riikonen S, Teramo K (2000) Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 79(9):744–749CrossRefPubMed Sainio S, Kekomaki R, Riikonen S, Teramo K (2000) Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 79(9):744–749CrossRefPubMed
10.
go back to reference Singh N, Sharma KA, Dadhwal V, Mittal S, Selvi AS (2008) A successful management of dengue fever in pregnancy: report of two cases. Indian J Med Microbiol 26(4):377–380CrossRefPubMed Singh N, Sharma KA, Dadhwal V, Mittal S, Selvi AS (2008) A successful management of dengue fever in pregnancy: report of two cases. Indian J Med Microbiol 26(4):377–380CrossRefPubMed
Metadata
Title
Thrombocytopenia and Its Outcome in a Cohort of 350 Pregnant Women in a Tertiary Care Setting
Authors
Farheen Karim
Bushra Moiz
Publication date
01-04-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-01070-w

Other articles of this Issue 2/2019

Indian Journal of Hematology and Blood Transfusion 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine